Admelog Solostar — Class II drug recall D-0925-2018
Ongoing recall by Sanofi-Aventis U.S. LLC, reported 2018-07-18, distributed nationwide. Temperature Abuse: Product samples of Admelog may not have been shipped at proper temperature.
| Recall number | D-0925-2018 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Ongoing |
| Voluntary or mandated | Voluntary |
| Recalling firm | Sanofi-Aventis U.S. LLC, Bridgewater, NJ, United States |
| Recall initiated | 2018-07-05 |
| Classified | 2018-07-16 |
| Reported by FDA | 2018-07-18 |
| Distributed | Nationwide (US) |
| Quantity | 3,214 prefilled |
| Reason classes | temperature control |
| NDC | 00024-5924, 00024-5924-10, 00024-5925, 00024-5925-00, 00024-5925-01, 00024-5925-05, 00024-5926, 00024-5926-05 |
| Lot numbers | 7F021B |
| Expiration dates | 2020-06-30 |
Product
Admelog Solostar (insulin lispro injection), 100 units/ mL (U-100) injection, packaged in 3mL prefilled pens, 1 pen per box, Rx only, Physician Sample - Not For Sale, Sanofi-Aventis U.S. LLC, Bridgewater, NJ 08807, NDC 0024-5925-00
Reason for recall
Temperature Abuse: Product samples of Admelog may not have been shipped at proper temperature.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0925-2018. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.